- Report
- October 2023
- 182 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- August 2025
- 82 Pages
India
From €3116EUR$3,500USD£2,723GBP
- Report
- September 2024
- 82 Pages
Japan
From €3116EUR$3,500USD£2,723GBP
- Report
- July 2024
- 185 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- February 2024
- 185 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- November 2023
- 188 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- October 2023
- 128 Pages
North America
From €3561EUR$4,000USD£3,112GBP
- Report
- February 2024
- 115 Pages
Global
From €4229EUR$4,750USD£3,695GBP
- Report
- April 2024
- 283 Pages
Global
From €3205EUR$3,600USD£2,801GBP
- Report
- January 2023
- 156 Pages
Europe
From €3071EUR$3,450USD£2,684GBP
- Report
- January 2023
- 135 Pages
Africa, Middle East
From €3071EUR$3,450USD£2,684GBP
- Report
- August 2022
- 104 Pages
From €3071EUR$3,450USD£2,684GBP
- Report
- March 2022
- 198 Pages
Global
From €3962EUR$4,450USD£3,462GBP
- Report
- October 2025
- 150 Pages
Germany
From €3427EUR$3,850USD£2,995GBP
- Report
- September 2025
- 150 Pages
China
From €3427EUR$3,850USD£2,995GBP
- Report
- November 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- September 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- September 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- September 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- November 2023
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more